High cumulative doxorubicin dose for advanced soft tissue sarcomaZhichao Tian, Xin Wang, Weitao Yao et al.|BMC Cancer|2020Cited by 41
Efficacy and safety of sintilimab plus doxorubicin in advanced soft tissue sarcoma: A single-arm, phase II trialZhichao Tian, Weitao Yao, Shuping Dong et al.|Frontiers in Pharmacology|2022Cited by 10
Argon-helium knife cryoablation plus programmed cell death protein 1 inhibitor in the treatment of advanced soft tissue sarcomas: there is no evidence of the synergistic effects of this combination therapyJiaqiang Wang, Zhichao Tian, Deng-Wei Zong et al.|Frontiers in Oncology|2023Cited by 4
Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectivesZhichao Tian, Weitao Yao, Jiaqiang Wang et al.|Frontiers in Pharmacology|2024Cited by 3